Therapeutic Percutaneous Embolization in Intractable Epistaxis

Sokoloff, Joel; Wickbom, Ingmar; McDonald, D. G.; Brahme, Folke; Goergen, Thomas G.; Goldberger, Lawrence E.

doi:10.1148/111.2.285

Cited by 205 publications

(95 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Angiographic embolization or endoscopic techniques for sphenopalatine artery ligation can be used for the control of intractable bleeding. Angiographic embolization for posterior epistaxis was first described in 1974 (25), with success rates ranging from 79% to 96% (26). Complications of embolization include rebleeding, stroke, blindness, facial numbness, skin sloughing, and groin hematoma.…”

Section: Discussionmentioning

confidence: 99%

Epistaxis in geriatric patients

Yüksel¹,

Kurtaran²,

Kankılıç³

et al. 2014

Turk J Med Sci

View full text Add to dashboard Cite

We studied, for the first time, the age structure of Eremias strauchi strauchi (Kessler, 1878) from a sample (18 adults) of a population living in the vicinity of Iğdır (eastern Turkey) using the skeletochronological method. The maximum observed longevity was 7 years for males and 5 years for females. The age of males ranged from 4 to 7 years (mean 4.91, n = 12), while that of females ranged from 4 to 5 years (mean 4.66, n = 6). The average snout-vent length (SVL) was 61.10 mm in males and 60.82 mm in females. The differences in mean age and SVL between sexes were not statistically significant. Intersexual differences in body size were male-biased, but this state was not statistically significant. Age and SVL were positively correlated in both sexes.

show abstract

Section: Discussionmentioning

confidence: 99%

Epistaxis in geriatric patients

Yüksel¹,

Kurtaran²,

Kankılıç³

et al. 2014

Turk J Med Sci

View full text Add to dashboard Cite

show abstract

“…More recently, endoscopic surgical procedures have been described for direct cauterization of the active bleeding site or ligation of the SPA. [13][14][15][16] Endovascular treatment of epistaxis was first presented as an alternative to surgery by Sokoloff et al in 1974 17 and consisted of particle embolization of the ipsilateral IMA. The technique was later refined by Lasjaunias et al, 18 stressing the need for a standardized angiographic and therapeutic approach.…”

mentioning

confidence: 99%

Endovascular Treatment of Epistaxis

Willems¹,

Farb²,

Agid³

2009

AJNR Am J Neuroradiol

118

110

View full text Add to dashboard Cite

SUMMARY:Epistaxis is a common condition that can be managed conservatively in most cases. When these measures, including anterior and posterior packing of the nasal cavity, are unsuccessful at controlling the bleeding, interruption of the blood supply to the sinonasal area can be performed, either by surgical ligation or by transarterial embolization. Embolization should be preceded by thorough diagnostic angiography. Aside from aiding with subsequent selective catheterization and embolization, such angiography may reveal significant anatomic anomalies, anastomoses, or an unsuspected cause of epistaxis. Taking these findings into account, the interventionalist may decide to refrain from embolization or adjust the technique to minimize the risk of adverse events, which are mostly related to inadvertent embolization of the internal carotid artery or ophthalmic artery. We present a review of the various causes of epistaxis and the treatment options, with emphasis on endovascular embolization. We also describe the protocol of our institution for endovascular management of this condition.

show abstract

“…Angioembolisation was introduced as a novel technique, alternate to surgery to treat uncontrollable bleeding by Sokoloff et al [9] in 1974. For controlling idiopathic intractable epistaxis, angioembolisation is reported to have a success rate of 75-97 % [7,10].…”

Section: Discussionmentioning

confidence: 99%

Angioembolisation in Maxillofacial Trauma: An Initial Experience in a Tertiary Care Center

Gamanagatti

Prasad

Kumar

et al. 2015

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

Purpose To analyze the safety, efficacy and outcome of angio-embolization in the management of refractory oronasal bleeding in patients of severe maxillofacial trauma. Materials and Methods It was a retrospective analysis of 21 patients who were managed by angio-embolisation to control refractory oro-nasal bleeding in severe maxillofacial trauma from December 2010 to December 2013. The patient population included 19 males and 2 females and the age ranged from 16 to 55 years (mean age of 29.6 years). Gelfoam pledgets and coils were used as embolising agents in branches of external carotid arteries. Embolising coils were preferably used to block actively bleeding vessels on angiography. Results Road traffic accidents were the etiology in 17 patients and fall from height (two), assault (one) and gunshot injury (one) in the rest. Twelve (52 %) patients showed active contrast extravasation on angiography. Active arterial bleeding was observed from branches of internal maxillary [11], facial [2] and lingual arteries [4]. Gel foam embolisation alone was done in 16 patients, coil embolisation alone in two patients and both coil and gel foam embolisation in three patients. The procedures were technically successful in twenty (95 %) patients. None of the patients had procedure related complications. Nine patients (42 %) succumbed to their associated injuries later, in which five patients had severe head injuries and four patients had history of hemorrhagic shock and cardiac arrest prior to the procedure. Conclusion Angio-embolisation is a safe and effective technique in managing intractable bleeding in maxillofacial injuries.

show abstract

Therapeutic Percutaneous Embolization in Intractable Epistaxis

Cited by 205 publications

References 11 publications

Epistaxis in geriatric patients

Epistaxis in geriatric patients

Endovascular Treatment of Epistaxis

Angioembolisation in Maxillofacial Trauma: An Initial Experience in a Tertiary Care Center

Contact Info

Product

Resources

About